TPM3 and ovarian cancer: However, a recent study found Tpm3 to be present in ovarian cancer patient sera at significantly elevated levels compared with controls [43], paralleling our own observation that Tpm3 is upregulated in CRC patient sera, and lending some support to further studies on the clinical usefulness of this protein.